The event diary contains full event literature for featured conferences - to get your conference or seminar featured, mail our sales staff.
Based on the 2008 Physician & Payer Forum report, ''The Impact of Razadyne's Genericization and the Launch of Biologic Disease-Modifying Drugs on the Alzheimer's Disease Market: Clinician and Payer Receptivity to Novel Agents'', Decision Resources is offering an exclusive, in-depth webinar entitled Disruptions in the Alzheimer's Disease Market: The Impact of Razadyne's Genericization and the Launch of Biologic Disease-Modifying Drugs.
Full literature available here